Toronto, ON - A new meta-analysis comparing angiotensin receptor blockers (ARBs) to placebo or ACE inhibitors in heart failure patients "cannot claim that ARBs are superior" to ACE inhibitors in ...
(UPDATED) Another observational study, in the form of a large analysis of US patients with hypertension, indicates that ACE inhibitors and ARBs are not associated with an increased risk of COVID-19 ...
Boston, MA - A new study shows a significant reduction in the incidence of Alzheimer's disease and dementia among subjects taking angiotensin-receptor blockers (ARBs), compared with those taking ACE ...
(UPDATED) Hospitalized patients with COVID-19 who continue on their previously prescribed ACE inhibitors and ARBs are not at an increased risk of dying or remaining in the hospital when compared to ...
Close-up of senior black woman sorting weekly medication. Member of a black middle class America family. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the ...
A new opinion piece published in the journal Circulation Research in April 2020 defends the use of antihypertensive drugs called ACE inhibitors and ARBs in patients with pandemic viral pneumonia ...
Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...
May 5 (UPI) --Certain high blood pressure medications have been linked with more serious illness from COVID-19, but they don't increase a person's risk for getting the disease, a new study published ...
Credit: Getty Images. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines. Angiotensin receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results